|
1
|
WHO: Hepatitis B. July 27, 2019.
urihttp://www.who.int/mediacentre/factsheets/fs204/en/simplehttp://www.who.int/mediacentre/factsheets/fs204/en/.
|
|
2
|
WHO: Hepatitis C. July 27, 2019.
urihttp://www.who.int/mediacentre/factsheets/fs164/en/simplehttp://www.who.int/mediacentre/factsheets/fs164/en/.
|
|
3
|
Umemura T, Ichijo T, Yoshizawa K, Tanaka E
and Kiyosawa K: Epidemiology of hepatocellular carcinoma in Japan.
J Gastroenterol. 44 (Suppl 19):S102–S107. 2009.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Omata M, Kanda T, Wei L, Yu ML, Chuang WL,
Ibrahim A, Lesmana CR, Sollano J, Kumar M, Jindal A, et al: APASL
consensus statements and recommendations for hepatitis C
prevention, epidemiology, and laboratory testing. Hepatol Int.
10:681–701. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Tanaka J, Akita T, Ohisa M, Sakamune K, Ko
K, Uchida S and Satake M: Trends in the total numbers of HBV and
HCV carriers in Japan from 2000 to 2011. J Viral Hepat. 25:363–372.
2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Tanaka J, Akita T, Ko K, Miura Y and
Satake M: Countermeasures against viral hepatitis B and C in Japan:
An epidemiological point of view. Hepatol Res. 49:990–1002.
2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Omata M, Nishiguchi S, Ueno Y, Mochizuki
H, Izumi N, Ikeda F, Toyoda H, Yokosuka O, Nirei K, Genda T, et al:
Sofosbuvir plus ribavirin in Japanese patients with chronic
genotype 2 HCV infection: An open-label, phase 3 trial. J Viral
Hepat. 21:762–768. 2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kumada H, Suzuki Y, Ikeda K, Toyota J,
Karino Y, Chayama K, Kawakami Y, Ido A, Yamamoto K, Takaguchi K, et
al: Daclatasvir plus asunaprevir for chronic HCV genotype 1b
infection. Hepatology. 59:2083–2091. 2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Mizokami M, Yokosuka O, Takehara T,
Sakamoto N, Korenaga M, Mochizuki H, Nakane K, Enomoto H, Ikeda F,
Yanase M, et al: Ledipasvir and sofosbuvir fixed-dose combination
with and without ribavirin for 12 weeks in treatment-naive and
previously treated Japanese patients with genotype 1 hepatitis C:
An open-label, randomised, phase 3 trial. Lancet Infect Dis.
15:645–653. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Chayama K, Suzuki F, Karino Y, Kawakami Y,
Sato K, Atarashi T, Naganuma A, Watanabe T, Eguchi Y, Yoshiji H, et
al: Efficacy and safety of glecaprevir/pibrentasvir in Japanese
patients with chronic genotype 1 hepatitis C virus infection with
and without cirrhosis. J Gastroenterol. 53:557–565. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Liaw YF, Sung JJ, Chow WC, Farrell G, Lee
CZ, Yuen H, Tanwandee T, Tao QM, Shue K, Keene ON, et al:
Lamivudine for patients with chronic hepatitis B and advanced liver
disease. N Engl J Med. 351:1521–1531. 2004.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chang TT, Gish RG, de Man R, Gadano A,
Sollano J, Chao YC, Lok AS, Han KH, Goodman Z, Zhu J, et al: A
comparison of entecavir and lamivudine for HBeAg-positive chronic
hepatitis B. N Engl J Med. 354:1001–1010. 2006.PubMed/NCBI View Article : Google Scholar
|
|
13
|
European Association for the Study of the
Liver. Electronic address: simpleeasloffice@easloffice.eu
and European Association for the Study of the Liver. EASL 2017
Clinical Practice Guidelines on the management of hepatitis B virus
infection. J Hepatol. 67:370–398. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Japanese low translation (Ministry of
Justice). Industrial Safety and Health Act. urihttp://www.japaneselawtranslation.go.jp/law/detail/?id=1926&vm=&resimplehttp://www.japaneselawtranslation.go.jp/law/detail/?id=1926&vm=&re.
|
|
15
|
Gerberding JL: Management of occupational
exposures to blood-borne viruses. N Engl J Med. 332:444–451.
1995.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Nagao Y, Chiba I and Sata M: Survey of
hepatitis B and C in students of faculty of dentistry and dental
hygienist school. Kansenshogaku Zasshi. 78:554–565. 2004.PubMed/NCBI View Article : Google Scholar : (In Japanese).
|
|
17
|
Nagao Y, Matsuoka H, Kawaguchi T, Ide T
and Sata M: HBV and HCV infection in Japanese dental care workers.
Int J Mol Med. 21:791–799. 2008.PubMed/NCBI
|
|
18
|
Nagao Y, Ozaki T, Kawaguchi A, Chiba I,
Harada K, Saito T and Shiratsuchi S: Survey of dental health care
workers regarding their knowledge of viral liver disease and
prevention of its transmission, using an online questionnaire. Adv
Res Gastroentero Hepatol. 10:95–108. 2018.
|
|
19
|
Nishijo T, Inoue R, Kurita T, Akita A,
Takano K and Kuroda H: A preliminary report of the vaccination of
hepatitis B vaccine to the medical stuff in Juntendo University
Hospital. Juntendo Med J. 34:232–235. 1988.
|
|
20
|
Okabe N, Arakawa S, Iwata S, Shiraishi T,
Taya K, Fujimoto T, Mikamo H and Yasuoka A: The first edition of
the vaccine guideline for nosocomial infections. Jap J
Environmental Infect. 24:S1–S11. 2009.(In Japanese).
|
|
21
|
Deguchi M, Kagita M, Yoshioka N, Tsukamoto
H, Takao M, Tahara K, Maeda I, Hidaka Y, Yamauchi S, Kaneko A, et
al: Evaluation of the highly sensitive chemiluminescent enzyme
immunoassay ‘Lumipulse HBsAg-HQ’ for hepatitis B virus screening. J
Clin Lab Anal. 32(e22334)2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Choi SJ, Park Y, Lee EY, Kim S and Kim HS:
Performance evaluation of LUMIPULSE G1200 autoimmunoanalyzer for
the detection of serum hepatitis B virus markers. J Clin Lab Anal.
27:204–206. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Bond WW, Favero MS, Petersen NJ, Gravelle
CR, Ebert JW and Maynard JE: Survival of hepatitis B virus after
drying and storage for one week. Lancet. 1:550–551. 1981.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kobayashi K: Questionnaire study of
needlestick injures and hepatitis B vaccination in general dental
practices. Jap J Environmental Infect. 30:348–353. 2015.(In
Japanese).
|
|
25
|
McCarthy GM, Koval JJ and MacDonald JK:
Occupational injuries and exposures among Canadian dentists: The
results of a national survey. Infect Control Hosp Epidemiol.
20:331–336. 1999.PubMed/NCBI View
Article : Google Scholar
|
|
26
|
Werner BG and Grady GF: Accidental
hepatitis-B-surface-antigen-positive inoculations Use of e antigen
to estimate infectivity. Ann Intern Med. 97:367–369.
1982.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Relation of e antigen to infectivity of
hBsAg-positive inoculations among medical personnel. Lancet.
1:492–494. 1976.PubMed/NCBI
|
|
28
|
Olubuyide IO, Ola SO, Aliyu B, Dosumu OO,
Arotiba JT, Olaleye OA, Odaibo GN, Odemuyiwa SO and Olawuyi F:
Hepatitis B and C in doctors and dentists in Nigeria. QJM.
90:417–422. 1997.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Vadivale M, Tan TC and Ong CN:
Sero-prevalence of hepatitis B infection among dental
professionals. Singapore Med J. 33:367–369. 1992.PubMed/NCBI
|
|
30
|
Batista SM, Andreasi MS, Borges AM,
Lindenberg AS, Silva AL, Fernandes TD, Pereira EF, Basmage EA and
Cardoso DD: Seropositivity for hepatitis B virus, vaccination
coverage, and vaccine response in dentists from Campo Grande, Mato
Grosso do Sul, Brazil. Mem Inst Oswaldo Cruz. 101:263–267.
2006.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Cleveland JL, Siew C, Lockwood SA,
Gruninger SE, Gooch BF and Shapiro CN: Hepatitis B vaccination and
infection among U.S. dentists, 1983-1992. J Am Dent Assoc.
127:1385–1390. 1996.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ammon A, Reichart PA, Pauli G and Petersen
LR: Hepatitis B and C among Berlin dental personnel: Incidence,
risk factors, and effectiveness of barrier prevention measures.
Epidemiol Infect. 125:407–413. 2000.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ahmad Akhoundi MS, Momeni N, Norouzi M,
Ghalichi L, Shamshiri AR, Alavian SM, Poortahmasebi V and Jazayeri
SM: Prevalence of blood-borne viruses among Iranian dentists:
Results of a national survey. Int J Occup Med Environ Health.
28:593–602. 2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Redd JT, Baumbach J, Kohn W, Nainan O,
Khristova M and Williams I: Patient-to-patient transmission of
hepatitis B virus associated with oral surgery. J Infect Dis.
195:1311–1314. 2007.PubMed/NCBI View
Article : Google Scholar
|
|
35
|
Seike M, Honda K, Endo M, Oribe J, Arakawa
M, Tokoro M, Iwao M, Otsu S and Murakami K: A case of acute
hepatitis C suspected to be infected by dental treatment. Kanzo. 58
(Suppl 3)(A880)2017.(In Japanese).
|
|
36
|
Nagao Y, Kawaguchi T, Ide T and Sata M:
HCV or HBV infection self-disclosure to dentists. Kansenshogaku
Zasshi. 82:213–219. 2008.PubMed/NCBI View Article : Google Scholar : (In Japanese).
|
|
37
|
Okabe N, Arakawa S, Iwata S, Ihara T,
Shiraishi T, Taya K, Fujimoto T, Mikamo H and Yasuoka A: The second
edition of the vaccine guideline for healthcare professionals. Jap
J Environmental Infec. 29 (Suppl 3):S1–S13. 2014.(In Japanese).
|
|
38
|
Mikamo H, Taya K, Ishiguro N, Iwata S,
Uchida M, Okada K, Kanai S, Toyokawa M, Nakano T, Fujimura S, et
al: The third edition of the vaccine guideline for healthcare
professionals. Jap J Environmental Infect. 35 (Suppl II):S1–S31.
2020.(In Japanese).
|
|
39
|
Piazza M, Borgia G, Picciotto L, Nappa S,
Cicciarello S and Orlando R: Detection of hepatitis C virus-RNA by
polymerase chain reaction in dental surgeries. J Med Virol.
45:40–42. 1995.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Hashish MH, Selim HS, Elshazly SA, Diab HH
and Elsayed NM: Screening for the hepatitis C virus in some dental
clinics in Alexandria, Egypt. J Egypt Public Health Assoc.
87:109–115. 2012.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Nagao Y, Seki N, Tamatsukuri S and Sata M:
Detection of hepatitis C virus in saliva before and after scaling
of dental calculus. Kansenshogaku Zasshi. 74:961–965.
2000.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Wang CC, Morishima C, Chung M, Engelberg
R, Krantz E, Krows M, Sullivan DG, Gretch DR and Corey L: High
serum hepatitis C virus (HCV) RNA load predicts the presence of HCV
RNA in saliva from individuals with chronic and acute HCV
infection. J Infect Dis. 193:672–676. 2006.PubMed/NCBI View
Article : Google Scholar
|
|
43
|
Banatvala JE and Van Damme P: Hepatitis B
vaccine-do we need boosters? J Viral Hepat. 10:1–6. 2003.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Ferreira RC, Guimaraes AL, Pereira RD,
Andrade RM, Xavier RP and Martins AM: Hepatitis B vaccination and
associated factors among dentists. Rev Bras Epidemiol. 15:315–323.
2012.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Survey of Physicians, Dentists and
Pharmacists. 2018, Ministry of Health, Labor and Welfare (In
Japanese). Accessed from: urihttps://www.mhlw.go.jp/toukei/saikin/hw/ishi/18/index.htmlsimplehttps://www.mhlw.go.jp/toukei/saikin/hw/ishi/18/index.html.
|
|
46
|
Nagao Y: The role of dentists in
controlling hepatocellular carcinoma in Japan (Review). Exp Ther
Med: Dec 3, 2020 (Epub ahead of print). doi:
org/10.3892/etm.2020.9545.
|
